1. Home
  2. IMVT vs ABR Comparison

IMVT vs ABR Comparison

Compare IMVT & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • ABR
  • Stock Information
  • Founded
  • IMVT 2018
  • ABR 2003
  • Country
  • IMVT United States
  • ABR United States
  • Employees
  • IMVT N/A
  • ABR N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • ABR Real Estate Investment Trusts
  • Sector
  • IMVT Health Care
  • ABR Real Estate
  • Exchange
  • IMVT Nasdaq
  • ABR Nasdaq
  • Market Cap
  • IMVT 2.7B
  • ABR 2.3B
  • IPO Year
  • IMVT N/A
  • ABR 2004
  • Fundamental
  • Price
  • IMVT $16.16
  • ABR $11.70
  • Analyst Decision
  • IMVT Buy
  • ABR Hold
  • Analyst Count
  • IMVT 11
  • ABR 5
  • Target Price
  • IMVT $33.88
  • ABR $12.38
  • AVG Volume (30 Days)
  • IMVT 1.5M
  • ABR 2.1M
  • Earning Date
  • IMVT 11-06-2025
  • ABR 10-31-2025
  • Dividend Yield
  • IMVT N/A
  • ABR 10.26%
  • EPS Growth
  • IMVT N/A
  • ABR N/A
  • EPS
  • IMVT N/A
  • ABR 0.91
  • Revenue
  • IMVT N/A
  • ABR $600,587,000.00
  • Revenue This Year
  • IMVT N/A
  • ABR N/A
  • Revenue Next Year
  • IMVT N/A
  • ABR $7.73
  • P/E Ratio
  • IMVT N/A
  • ABR $12.92
  • Revenue Growth
  • IMVT N/A
  • ABR N/A
  • 52 Week Low
  • IMVT $12.72
  • ABR $8.43
  • 52 Week High
  • IMVT $32.10
  • ABR $15.94
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 51.87
  • ABR 48.96
  • Support Level
  • IMVT $16.08
  • ABR $11.52
  • Resistance Level
  • IMVT $17.20
  • ABR $12.03
  • Average True Range (ATR)
  • IMVT 0.77
  • ABR 0.23
  • MACD
  • IMVT 0.16
  • ABR -0.03
  • Stochastic Oscillator
  • IMVT 58.68
  • ABR 23.68

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.

Share on Social Networks: